Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

cps cito pharma services gmbh - colestyraminum-20 - polvere - colestyraminum-20 4 g, propylenglycoli alginas 100 mg, xanthani gummi, acidum citricum, silica colloidalis anhydrica, aromatica, aspartamum 30 mg ad pulverem pro charta. - lipidsenker - synthetika

Eiropas Savienība - itāļu - EMA (European Medicines Agency)

orion corporation - toremifene - neoplasie al seno - terapia endocrina - trattamento ormonale di prima linea del carcinoma mammario metastatico ormone-dipendente nei pazienti in postmenopausa. fareston non è raccomandato per i pazienti con il recettore per gli estrogeni negativi tumori.

Eiropas Savienība - itāļu - EMA (European Medicines Agency)

astellas pharma europe b.v. - enzalutamide - neoplasie prostatiche - terapia endocrina - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

cps cito pharma services gmbh - celiprololi hydrochloridum - compresse rivestite con film - celiprololi hydrochloridum 200 mg, mannitolum, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, e 171, hypromellosum, macrogolum 400, macrogolum 6000, pro compresso obducto corresp. natrium 65 µg. - betablocker - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

cps cito pharma services gmbh - flunitrazepamum - compresse rivestite con film - flunitrazepamum 1 mg, lactosum 117 mg, cellulosum microcristallinum, hypromellosum, povidonum k 90, carboxymethylamylum natricum a, e 132, magnesii stearas, Überzug: hypromellosum, ethylcellulosum, talcum, e 171, e 172 (flavum), triacetinum, e 132, pro compresso obducto corresp. natrium 0.21 mg. - hypnoticum - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

cps cito pharma services gmbh - peginterferonum alfa-2a - soluzione iniettabile in siringa preriempita - peginterferonum alfa-2a 135 µg, natrii chloridum, alcohol benzylicus 5 mg, natrii acetas trihydricus, acidum aceticum glaciale, polysorbatum 80, natrii acetas trihydricus aut acidum aceticum ad ph, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 1.8 mg. - chronische epatite b; chronische epatite c - biotechnologika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

cps cito pharma services gmbh - peginterferonum alfa-2a - soluzione iniettabile in siringa preriempita - peginterferonum alfa-2a 180 µg, natrii chloridum, alcohol benzylicus 5 mg, natrii acetas trihydricus, acidum aceticum glaciale, polysorbatum 80, natrii acetas trihydricus aut acidum aceticum ad ph, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 1.8 mg. - chronische epatite b; chronische epatite c - biotechnologika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

cps cito pharma services gmbh - darifenacinum - retardtabletten - darifenacinum 7.5 mg ut darifenacini hydrobromidum, calcii hydrogenophosphas dihydricus, hypromellosum, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, talcum, e 171, pro compresso obducto. - trattamento della vescica iperattiva - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

cps cito pharma services gmbh - darifenacinum - retardtabletten - darifenacinum 15 mg ut darifenacini hydrobromidum, calcii hydrogenophosphas dihydricus, hypromellosum, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, talcum, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - trattamento della vescica iperattiva - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

bracco suisse sa - gadoteridolum - soluzione iniettabile (flacone) - gadoteridolum 279.3 mg corresp. 0.5 mmol, calteridolum calcicum, trometamolum, acidum hydrochloridum aut natrii hydroxidum corresp. natrium max 57.5 µg, aqua ad iniectabile ad solutionem pro 1 ml. - mezzo di contrasto per la tmr diagnostica del snc - synthetika